Cited by 31HIV/AIDS Research and InterventionsReproductive tract infections researchHIV, Drug Use, Sexual Risk

Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.

Tang, Eric C., Vittinghoff, Eric, Philip, Susan S., Doblecki-Lewis, Susanne, Bacon, Oliver, Chege, Wairimu, Coleman, Megan E., Elion, Richard +4 more·2020·AIDS

Abstract

OBJECTIVE: The optimal screening frequency of sexually transmitted infections (STIs) for MSM and transgender women (TGW) on HIV pre-exposure prophylaxis (PrEP) is unclear, with present guidelines recommending screening every 3-6 months. We aimed to determine the number of STIs for which treatment would have been delayed without quarterly screening. DESIGN: The US PrEP Demonstration Project was a prospective, open-label cohort study that evaluated PrEP delivery in STI clinics in San Francisco and Miami, and a community health center in Washington, DC. In all, 557 HIV-uninfected MSM and TGW were offered up to 48 weeks of PrEP and screened quarterly for STIs. METHODS: The proportion of gonorrhea, chlamydia, and syphilis infections for which treatment would have been delayed had screening been conducted every 6 versus every 3 months was determined by taking the number of asymptomatic STIs at weeks 12 and 36 divided by the total number of infections during the study follow-up period for each STI. RESULTS: Among the participants, 50.9% had an STI during follow-up. If screening had been conducted only semiannually or based on symptoms, identification of 34.3% of gonorrhea, 40.0% of chlamydia, and 20.4% of syphilis infections would have been delayed by up to 3 months. The vast majority of participants (89.2%) with asymptomatic STIs reported condomless anal sex and had a mean of 8.1 partners between quarterly visits. CONCLUSIONS: Quarterly STI screening among MSM on PrEP could prevent a substantial number of partners from being exposed to asymptomatic STIs, and decrease transmission.

Integrity signals

Registry

Crossref · 10.1097/qad.0000000000002522

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies have reported that MSM taking PrEP have high rates of STIs, and frequent screening is warranted.

    “Studies have reported that MSM taking PrEP have high rates of STIs, and frequent screening is warranted (204–206).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [206]

  • Quarterly screening was reported to have prevented STI exposure in a median of three sex partners per STI infection.

    “In addition, quarterly screening was reported to have prevented STI exposure in a median of three sex partners per STI infection (206).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [206]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., Liu, A. Y., & Cohen, S. E.
Affiliations
  • California Department of Public Health (US)
  • University of California, San Francisco (US)
  • University of Miami, Miller School of Medicine, Miami, FL
  • National Institutes of Health (US)
  • Whitman-Walker Health (US)
  • Washington DC Department of Health, Center for Sexual Health, Washington, DC, USA.
  • University of Miami (US)
Corresponding author
  • Tang, Eric C.
  • Cohen, Stephanie E.
Venue
AIDS
Published
2020-03-19
Volume
34
Issue
8
Pages
1181-1186
ISSN
  • 0269-9370 (ISSN-L)
  • 1473-5571
OpenAlex
W3012908993
Cited by
31
References
29
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 3
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Locations
  • AIDS (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R01MH095628)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords
sexually transmitted infections, HIV pre-exposure prophylaxis, screening frequency, men who have sex with men, transgender women, gonorrhea, chlamydia, syphilis, condomless anal sex
MeSH terms
Adolescent, Adult, Aged, Chlamydia Infections, Female, Gonorrhea, Humans, Male, Mass Screening, Middle Aged, Prospective Studies, San Francisco, Sexually Transmitted Diseases, Cohort Studies, HIV Infections, Homosexuality, Male, Delivery of Health Care, Integrated, Young Adult, Transgender Persons, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review